1687. Omadacycline in Female Adults With Acute Pyelonephritis: Results from a Randomized, Double-Blind, Adaptive Phase 2 Study

BACKGROUND: Omadacycline (OMC) is a novel intravenous (IV) and oral aminomethylcycline, approved in the USA for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in adults. We present data from a randomized, adaptive dose–response phase 2 study of OMC in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Overcash, J Scott, Tzanis, Evan, Manley, Amy, Kirsch, Courtney, Serio, Alisa W, White, Tiffany, Wright, Kelly, Chitra, Surya, Eckburg, Paul B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777848/
http://dx.doi.org/10.1093/ofid/ofaa439.1865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777848/
http://dx.doi.org/10.1093/ofid/ofaa439.1865

Ejemplares similares